DUBLIN–(BUSINESS WIRE)–The “Global Tonometers Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The tonometers market will register a CAGR of more than 5% by 2022. Introduction of home tonometry to gain traction in the market. Home tonometry improves understanding and management of glaucoma. Also, the growing popularity of self-testing diagnostics is likely to encourage end-users. Market Overview Increasing prevalence of ocular diseases Growing incidences of ocular
Category: Business
Yukon Supports ShoreView Industries' Partnership with California Retina Associates
MINNEAPOLIS–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/pe?src=hash" target="_blank"gt;#pelt;/agt;–Yukon Partners, provider of mezzanine capital for private equity transactions, is pleased to announce its investment in…
Global Phacoemulsification Devices (Consumables & Systems) Market 2019-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Phacoemulsification Devices Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The phacoemulsification devices market will register a CAGR of close to 4% by 2023. Glaucoma surgery combined with cataract surgery via phacoemulsification to gain traction in the market. Concomitant phacoemulsification and glaucoma surgery are together a viable treatment option for patients with both cataract and glaucoma. The minimally invasive glaucom
Fishkind, Bakewell, Maltzman, Hunter and Associates Eye Care & Surgery Center Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
TUCSON, Ariz.–(BUSINESS WIRE)–Fishkind, Bakewell, Maltzman, Hunter and Associates Eye Care & Surgery Center joins the AcuFocus IC-8® Lens Clinical Study for patients with cataracts.
Kala Pharmaceuticals Announces the Launch of INVELTYS™ and the Hiring of a Specialty Ophthalmology Sales Organization
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals announces the launch of INVELTYS and the hiring of a specialty ophthalmology sales organization.
NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance
EMERYVILLE, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Dryeye?src=hash" target="_blank"gt;#Dryeyelt;/agt;–NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance
Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Study Supporting Clinical Development in Japan
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Katalyst Surgical Files FTC Complaint Urging Investigation into Iridex Corporation for Anticompetitive Business Practices
CHESTERFIELD, Mo.–(BUSINESS WIRE)–Katalyst Surgical Files FTC Complaint Urging Investigation into Iridex Corporation for Anticompetitive Business Practices
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Glenn P. Sblendorio, CEO and President, will present an overview of the Company at the J.P. Morgan Healthcare Conference.
Western Dental Completes Acquisition of EyeMax Vision Plan and is Set to Begin Offering Vision Coverage to Groups and Individuals in California
ORANGE, Calif.–(BUSINESS WIRE)–Premier Dental Holdings, Inc., parent of Western Dental Services, has completed the purchase of EyeMax Vision Plan, a Knox-Keene licensed specialized health care service plan for vision. EyeMax recently completed the bu…
OcuSciences Announces Publication Showing Flavoprotein Fluorescence May Detect Improvement in Metabolic Function Preceding Structural Improvement in Patients with Diabetic Macular Edema Treated with Anti-VEGF
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, Inc., a clinical-stage biotechnology company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the online publication of its diabetic macular edem…
Kedalion Therapeutics to Present at Biotech Showcase 2019
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics, Inc., a clinical-stage company focused on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream™ platform, today announced that Pete…
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors
NEW YORK–(BUSINESS WIRE)–Ophthotech announced the election of Calvin (Cal) W. Roberts, M.D., to Its Board of Directors, effective as of January 1.
Ocular Therapeutix™ Announces Completion of Debt Refinancing
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank"gt;#OCUTXlt…
Eye Health America Celebrates Record-Breaking First Year
ATLANTA–(BUSINESS WIRE)–Eye Health America (EHA), a leader in eye care practice management, announced today its 2018 end-of-year recap, which included seven acquisitions of ophthalmology and optometry practices and ambulatory surgery centers across t…
2019 New Year’s Resolution: Give Your Eyes a Rest
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Employee benefits company Unum found nearly 40% of U.S. adults spend 12+ hours a day on devices, triggering symptoms of digital eye strain.
The Global Market for Ophthalmic Lasers (2018-2023) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Laser Market – Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Ophthalmic Laser market is projected to grow at a CAGR of 6.09% to reach US$706.588 million by 2023, from US$495.529 million in 2017. Growing prevalence of ophthalmic diseases like glaucoma, cataract and other vision related issues and increasing initiatives by the government to control visual impairment are expected to drive the growth of the mark
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Satralizumab von Chugai erhält von FDA den Status „Breakthrough Therapy“ für Neuromyelitis optica und Neuromyelitis-optica-Spektrum-Erkrankungen
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) gab bekannt, dass die US-amerikanische Zulassungsbehörde FDA den Status „Breakthrough Therapy“ (Durchbruchtherapie) für Chugais humanisierten, rezyklierenden An…
Physicians’ Education Resource® Presents the 16th Annual Winter Lung Cancer Conference™
CRANBURY, N.J.–(BUSINESS WIRE)–Physicians’ Education Resource® Presents the 16th Annual Winter Lung Cancer Conference™